重度の肺炎に対するリチューニング注射の有効性と安全性: 体系的なレビューとメタ解析
Yan Wang1,2, Baichuan Xu1,2, Peng Zhang1,2
1National Regional Traditional Chinese Medicine (Lung Disease) Diagnosis and Treatment Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Frontiers in pharmacology
|August 27, 2025
まとめ
重症性肺炎 (SP) の患者の臨床有効性を改善する. この伝統的な中国薬の補助療法により 発熱,咳,入院時間が短縮されます.
科学分野:
- 統合医療
- 肺科
- 薬理学について
背景:
- 伝統的な中国医学 (TCM) のエキスであるReduning (RDN) の注射は,中国で重症肺炎 (SP) の補助療法として使用されています.
- SPの治療におけるRDN注射の有効性と安全性を裏付ける臨床的証拠は,体系的な検証を必要とする.
研究 の 目的:
- 重度の肺炎 (SP) の補助療法としてのReduning (RDN) 注射の有効性と安全性を体系的に評価する.
主な方法:
- 2024年4月6日までの複数のデータベース (CNKI,WanFang,VIP,SinoMed,PubMed,Embase,Cochrane Library,Web of Science) から得られたランダム化制御試験 (RCT) のメタ分析が行われました.
- 1, 897人のSP患者を対象とした22件の試験を対象とした. 主な評価は臨床効果であった.
- バイアスのリスクは,コクランバイアスのリスク評価ツール2 (RoB2) を使用して評価されました.
主要な成果:
- 通常の治療または抗生物質治療と併用したRDN注射は,単独の治療と比較して臨床有効性を有意に改善しました (RR = 1.25, 95% CI [1. 20, 1. 30]).
- RDN注射により,発熱の減少 (MD = - 1. 55日),咳の消失 (MD = - 1. 97日),肺炎の解消 (MD = - 2. 39日),胸部X線改善 (MD = - 2. 73日),および入院 (MD = - 3. 11日) が短縮されました.
- APACHE IIスケールでは有意な改善は認められませんでした (MD=2. 45ポイント,p=0. 19);いくつかの副作用が報告されましたが,すべての研究では重篤なイベントが一貫して記録されていません.
結論:
- RDNの注射は,SPの補助療法として,臨床結果を向上させ,回復を加速させる可能性を示しています.
- RDNの注射は発熱の減少,咳の解消,入院期間の短縮など,重要な回復指標を改善することを示唆しています.
- これらの発見を確認し,治療プロトコルを標準化するために,さらに大規模な,よく設計された臨床試験が推奨されます.
関連する概念動画
01:28Pneumonia IV: Management
447
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
447
01:30Pneumonia V: Nursing management and Prevention
2.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.5K
01:30Pneumonia III: Complications and Assessment
435
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
435
01:17Drugs Used in Lower Respiratory Disorders: Overview
578
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578
01:29Pneumonia II: Pathophysiology
549
The pathophysiology of pneumonia involves the following steps:
549
01:26COPD: Management Using Bronchodilators and Corticosteroids
307
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
307